AnaptysBio, Inc.ANABNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank92
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
28.45%
↑ 106% vs avg
Percentile
P92
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
-482.14%
Historical baseline
PeriodValueYoY Change
TTM28.45%+128.0%
2024-101.60%+88.9%
2023-911.70%+10.9%
2022-1023.20%-1060.4%
2021-88.18%-241.4%
2020-25.83%+97.8%
2019-1199.16%-0.1%
2018-1197.62%-326.0%
2017-281.12%-1214.5%
2016-21.39%-